Document is current
Any future updates will be listed below
-
Authors
Petruzzella, Aaron https://orcid.org/0000-0002-7616-2271
Bruand, Marine https://orcid.org/0000-0001-8651-4800
Santamaria-Martínez, Albert https://orcid.org/0000-0001-5436-9207
Katanayeva, Natalya https://orcid.org/0000-0002-4240-1254
Reymond, Luc https://orcid.org/0000-0001-5282-9273
Wehrle, Sarah
Georgeon, Sandrine https://orcid.org/0000-0002-8158-4508
Inel, Damla
van Dalen, Floris J.
Viertl, David
Lau, Kelvin https://orcid.org/0000-0002-9040-7597
Pojer, Florence https://orcid.org/0000-0002-9183-7206
Schottelius, Margret
Zoete, Vincent https://orcid.org/0000-0002-2336-6537
Verdoes, Martijn https://orcid.org/0000-0001-8753-3528
Arber, Caroline https://orcid.org/0000-0001-6440-9970
Correia, Bruno E. https://orcid.org/0000-0002-7377-8636
Oricchio, Elisa https://orcid.org/0000-0002-1690-0447
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSK-3_190639)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSK-3_190639)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSK-3_190639)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSK-3_190639)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSK-3_190639)
Krebsliga Schweiz (KFS-5000-02-2020)
- License Information
-
More Information
Article History
Received: 10 July 2023
Accepted: 18 April 2024
First Online: 29 May 2024
Change Date: 15 August 2024
Change Type: Update
Change Details: In the version of this article initially published, the top third section of Fig. was missing and is now restored in the HTML and PDF versions of the article.
Competing interests
: EPFL has filed two provisional patent applications that incorporate the findings presented in this Article. E.O., A.P. and B.E.C. are named as coinventors on the first patent (European Patent Office, PCT International Application Number РСТ/EP2022/073211). E.O. and A.P. are also named as coinventors on the second patent (European Patent Office, Application Number EP24157666.9). The two patent applications cover the structure of the cathepsin inhibitors described in this study. The remaining authors declare no competing interests.
